AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
12:35
Emilia Șercan criticizes Nicușor Dan after the answers about Pahonțu: "It is a disgrace for the idea of democracy. He has definitively separated from everything that means the idea of honesty in politics."
12:22
Alexandru Hazem Kansou, the leader of the PSD group in CGMB, resigned on Friday from the position of general councilor to avoid incompatibility.
12:02
Claudiu Năsui, appointed Minister of Economy in the Republic of Moldova: The top priority is European integration
11:39
The USA, South Korea, and Japan will conduct a joint military exercise to test preparedness against nuclear threats from North Korea.
11:36
Romania could have a new designated prime minister by the end of next week / What would be Nicușor Dan's preferred scenario
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
